BlackRock Advisors’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $127K | Buy |
904
+143
| +19% | +$20.1K | ﹤0.01% | 2849 |
|
|
2016
Q3 | $111K | Buy |
761
+100
| +15% | +$14.6K | ﹤0.01% | 2911 |
|
|
2016
Q2 | $67K | Buy |
661
+7
| +1% | +$710 | ﹤0.01% | 3086 |
|
|
2016
Q1 | $87K | Hold |
654
| – | – | ﹤0.01% | 2925 |
|
|
2015
Q4 | $130K | Sell |
654
-283
| -30% | -$56.3K | ﹤0.01% | 2762 |
|
|
2015
Q3 | $148K | Sell |
937
-17,956
| -95% | -$2.84M | ﹤0.01% | 2854 |
|
|
2015
Q2 | $7.71M | Buy |
18,893
+310
| +2% | +$127K | 0.01% | 826 |
|
|
2015
Q1 | $8.53M | Sell |
18,583
-21,903
| -54% | -$10.1M | 0.01% | 820 |
|
|
2014
Q4 | $22.7M | Sell |
40,486
-7,792
| -16% | -$4.37M | 0.02% | 510 |
|
|
2014
Q3 | $25.3M | Sell |
48,278
-851
| -2% | -$446K | 0.03% | 504 |
|
|
2014
Q2 | $34.3M | Buy |
49,129
+6,620
| +16% | +$4.62M | 0.03% | 428 |
|
|
2014
Q1 | $19.7M | Buy |
42,509
+20,721
| +95% | +$9.6M | 0.02% | 541 |
|
|
2013
Q4 | $7.49M | Buy |
+21,788
| New | +$7.49M | 0.01% | 872 |
|